Trial Profile
An 8 week, non-selected, cohort, study to investigate whether the treatment of reflux induced cough alters associated bronchial hyperresponsiveness.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2019
Price :
$35
*
At a glance
- Drugs Omeprazole (Primary) ; Ranitidine
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 07 Jul 2011 New trial record